Skip to main content
. 2021 Nov 16;32(12):2507–2515. doi: 10.1021/acs.bioconjchem.1c00473

Figure 3.

Figure 3

(A) Chromatogram from size-exclusion chromatography on an AdvanceBio SEC column of GAGs from A549 cells treated with XylNapN3 (dashed bold line), XylNap (solid line), and XylNapOH (line with long dashes). The indicated molecular weights were obtained using heparin standards. (B) Amount of GAGs primed by A549 cells, as determined by disaccharide analysis. (C) Disaccharide analysis results after the treatment of A549 cells with XylNap (black bars), XylNapOH (gray bars), or XylNapN3 (white bars).